Cancer/Tumor Profiling Market Share, Size Global Historical Analysis, Segmentation, Application, Technology, Trends and Opportunities Forecasts to 2018 - 2026

                                                                       
Cancer/tumor profiling provides information about the genes that cause cancer, which can provide useful insights into the cancer mechanism.

        Cancer/Tumor Profiling Market


Cancer/tumor profiling provides information about the genes that cause cancer, which can provide useful insights into the cancer mechanism. Cancer profiling is useful not only for common cancers like lymphoma and breast cancer, but also for molecular profiling of lung cancer, prostate cancer, and acute leukaemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumours helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.

The global market is being driven by oncologists' increasing demand for cancer profiling methods to diagnose or treat cancers as well as predict response to targeted therapy. Furthermore, an increase in the use of cancer biomarkers for tumour profiling, an increase in the incidence of cancer around the world, and an increase in the use of next-generation sequencing techniques for cancer profiling drive market growth. However, high monetary investments in the development of biomarkers, as well as a scarcity of skilled professionals or oncologists specialising in tumour profiling, are impeding market growth.

The high cost of cancer profiling tests, as well as a lack of access to the healthcare infrastructure needed for cancer profiling, are limiting the growth of the Cancer/Tumor Profiling Market over the forecast period. Tumor profiling tests are cutting-edge, and they work by identifying tumour mutations and developing a therapy pathway tailored to the patient's specific needs. Because of the exorbitant cost of these sophisticated technology tests, they are only used by a small percentage of the population in economically depressed areas.

Market Segmentation:

By Technique

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

By Application
  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research Applications
Some of the major key players operating in the global cancer profiling market include Proteome Sciences PLC, Life Technologies Corporation, Illumina, Inc., BioTheranostics, RiboMed Biotechnologies Inc., NeoGenomics Laboratories, Oxford Gene Technology Ltd., Genomic Health Inc., Agendia, and Oncopath Laboratories.

Comments

Popular posts from this blog

Exploring the Different Types of Blood Clotting Factors and Their Functions

Aromatherapy Market: A Scent-Sational Journey to Wellness and Market Growth

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.